IgG antibodies to cyclic citrullinated peptides exhibit profiles specific in terms of IgG subclasses, Fc-glycans and a fab- Peptide sequence

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Lundström, Susanna L ^a   Fernes Cerqueira, Cátia ^a   Ytterberg, A Jimmy ^a   Ossipova, Elena ^a   Hensvold, Aase H ^a   Jakobsson, Per Johan ^a   Malmström, Vivianne ^a   Catrina, Anca I ^a   Klareskog, Lars ^a   Lundberg, Karin ^a   Zubarev, Roman A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; FC RECEPTOR; GLYCAN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2 ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN G4 ANTIBODY; UNCLASSIFIED DRUG; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; GLYCOPEPTIDE; IMMUNOGLOBULIN FRAGMENT; IMMUNOGLOBULIN G; POLYSACCHARIDE;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; PROTEIN GLYCOSYLATION; PROTEOMICS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; TANDEM MASS SPECTROMETRY; AMINO ACID SEQUENCE; BLOOD; CHEMISTRY; IMMUNOLOGY; MIDDLE AGED; MOLECULAR GENETICS; YOUNG ADULT;

ADULT; AGED; AMINO ACID SEQUENCE; ARTHRITIS, RHEUMATOID; FEMALE; GLYCOPEPTIDES; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN G; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDES, CYCLIC; POLYSACCHARIDES; SYNOVIAL FLUID; YOUNG ADULT;

EID: 84913534828     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113924     Document Type: Article

References (52)

1. Arend WP, Firestein GS (2012) Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis. Nat Rev Rheumatol 8:573-586.
2. Klareskog L, Lundberg K, Malmstrom V (2013) Autoimmunity in rheumatoid arthritis: citrulline immunity and beyond. Adv Immunol 118:129-158.
3. Klareskog L, Catrina AI, Paget S (2009) Rheumatoid arthritis. Lancet 373:659-672.
4. McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205-2219.
5. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, et al. (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48:2741-2749.
6. Kastbom A, Strandberg G, Lindroos A, Skogh T (2004) Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 63:1085-1089.
7. Scherer HU, van der Woude D, Ioan-Facsinay A, el Bannoudi H, Trouw LA, et al. (2010) Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid. Arthritis Rheum 62:1620-1629.
8. Engelmann R, Brandt J, Eggert M, Karberg K, Krause A, et al. (2008) IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA. Rheumatology (Oxford) 47:1489-1492.
9. Chapuy-Regaud S, Nogueira L, Clavel C, Sebbag M, Vincent C, et al. (2005) IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin. Clin Exp Immunol 139:542-550.
10. Rombouts Y, Ewing E, van de Stadt LA, Selman MH, Trouw LA, et al. (2013) Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann Rheum Dis
11. Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, et al. (2009) Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 113:3716-3725.
12. Karsten CM, Kohl J (2012) The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases. Immunobiology 217:1067-1079.
13. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, et al. (1995) Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1:237-243.
14. Anthony RM, Wermeling F, Ravetch JV (2012) Novel roles for the IgG Fc glycan. Ann N Y Acad Sci 1253:170-180.
15. Huck S, Fort P, Crawford DH, Lefranc MP, Lefranc G (1986) Sequence of a human immunoglobulin gamma 3 heavy chain constant region gene: comparison with the other human C gamma genes. Nucleic Acids Res 14:1779-1789.
16. Jefferis R, Lefranc MP (2009) Human immunoglobulin allotypes: possible implications for immunogenicity. MAbs 1:332-338.
17. Balbin M, Grubb A, de Lange GG, Grubb R (1994) DNA sequences specific for Caucasian G3m(b) and (g) allotypes: allotyping at the genomic level. Immunogenetics 39:187-193.
18. Oxelius VA, Eibl MM (1996) Different Gm allotype amounts in human intravenous immunoglobulin (IVIG) preparations; survival of foreign Gm allotypes in immunodeficient patients. Clin Exp Immunol 106:203-207.
19. Royle L, Campbell MP, Radcliffe CM, White DM, Harvey DJ, et al. (2008) HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem 376:1-12.
20. Pucic M, Knezevic A, Vidic J, Adamczyk B, Novokmet M, et al. (2011) High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol Cell Proteomics 10:M111 010090.
21. Shields RL, Lai J, Keck R, O'Connell LY, Hong K, et al. (2002) Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem 277:26733-26740.
22. Davies J, Jiang L, Pan LZ, LaBarre MJ, Anderson D, et al. (2001) Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII. Biotechnol Bioeng 74:288-294.
23. Anthony RM, Wermeling F, Karlsson MC, Ravetch JV (2008) Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc Natl Acad Sci U S A. 105:19571-19578.
24. Gornik I, Maravic G, Dumic J, Flogel M, Lauc G (1999) Fucosylation of IgG heavy chains is increased in rheumatoid arthritis. Clin Biochem 32:605-608.
25. van de Geijn FE, Wuhrer M, Selman MH, Willemsen SP, de Man YA, et al. (2009) Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study. Arthritis Res Ther 11:R193.
26. Parekh RB, Roitt IM, Isenberg DA, Dwek RA, Ansell BM, et al. (1988) Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. Lancet 1:966-969.
27. Nakagawa H, Hato M, Takegawa Y, Deguchi K, Ito H, et al. (2007) Detection of altered N-glycan profiles in whole serum from rheumatoid arthritis patients. J Chromatogr B Analyt Technol Biomed Life Sci 853:133-137.
28. Lundstrom SL, Yang H, Lyutvinskiy Y, Rutishauser D, Herukka SK, et al. (2014) Blood Plasma IgG Fc Glycans are Significantly Altered in Alzheimer's Disease and Progressive Mild Cognitive Impairment. J Alzheimers Dis 38:567-579.
29. Raza K, Saber TP, Kvien TK, Tak PP, Gerlag DM (2012) Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials. Ann Rheum Dis 71.:1921-1923.
30. Ossipova E, Cerqueira CF, Reed E, Kharlamova N, Israelsson L, et al. (2014) Affinity purified anticitrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint. Arthritis Res Ther 16:R167.
31. Lyutvinskiy Y, Yang H, Rutishauser D, Zubarev RA (2013) In silico instrumental response correction improves precision of label-free proteomics and accuracy of proteomics-based predictive models. Mol Cell Proteomics 12:2324-2331.
32. Abel CA, Spiegelberg HL, Grey HM (1968) The carbohydrate contents of fragments and polypeptide chains of human gamma-G-myeloma proteins of different heavy-chain subclasses. Biochemistry 7:1271-1278.
33. Burton DR, Woof JM (1992) Human antibody effector function. Adv Immunol 51:1-84.
34. van der Neut Kolfschoten M, Schuurman J, Losen M, Bleeker WK, Martinez-Martinez P, et al. (2007) Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 317:1554-1557.
35. Zack DJ, Stempniak M, Wong AL, Weisbart RH (1995) Localization of an Fc-binding reactivity to the constant region of human IgG4. Implications for the pathogenesis of rheumatoid arthritis. J Immunol 155:5057-5063.
36. Kawa S, Kitahara K, Hamano H, Ozaki Y, Arakura N, et al. (2008) A novel immunoglobulinimmunoglobulin interaction in autoimmunity. PLoS One 3:e1637.
37. Aalberse RC, Stapel SO, Schuurman J, Rispens T (2009) Immunoglobulin G4: an odd antibody. Clin Exp Allergy 39:469-477.
38. Cohen PL, Cheek RL, Hadler JA, Yount WJ, Eisenberg RA (1987) The subclass distribution of human IgG rheumatoid factor. J Immunol 139:1466-1471.
39. Rispens T, Ooievaar-De Heer P, Vermeulen E, Schuurman J, van der Neut Kolfschoten M, et al. (2009) Human IgG4 binds to IgG4 and conformationally altered IgG1 via Fc-Fc interactions. J Immunol 182:4275-4281.
40. Amara K, Steen J, Murray F, Morbach H, Fernandez-Rodriguez BM, et al. (2013) Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J Exp Med 210:445-455.
41. Willemze A, Shi J, Mulder M, Stoeken-Rijsbergen G, Drijfhout JW, et al. (2013) The concentration of anticitrullinated protein antibodies in serum and synovial fluid in relation to total immunoglobulin concentrations. Ann Rheum Dis 72:1059-1063.
42. Singh V, Stoop MP, Stingl C, Luitwieler RL, Dekker LJ, et al. (2013) Cerebrospinal-fluid-derived immunoglobulin G of different multiple sclerosis patients shares mutated sequences in complementarity determining regions. Mol Cell Proteomics 12:3924-3934.
43. Scheid JF, Mouquet H, Ueberheide B, Diskin R, Klein F, et al. (2011) Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333:1633-1637.
44. VanDuijn MM, Dekker LJ, Zeneyedpour L, Smitt PA, Luider TM (2010) Immune responses are characterized by specific shared immunoglobulin peptides that can be detected by proteomic techniques. J Biol Chem 285:29247-29253.
45. Thurgood LA, Arentz G, Lindop R, Jackson MW, Whyte AF, et al. (2013) An immunodominant La/ SSB autoantibody proteome derives from public clonotypes. Clin Exp Immunol 174:237-244.
46. Hoogeboom R, van Kessel KP, Hochstenbach F, Wormhoudt TA, Reinten RJ, et al. (2013) A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi. J Exp Med 210:59-70.
47. Maat P, VanDuijn M, Brouwer E, Dekker L, Zeneyedpour L, et al. (2012) Mass spectrometric detection of antigen-specific immunoglobulin peptides in paraneoplastic patient sera. J Autoimmun 38:354-360.
48. Sletten K, Natvig JB, Husby G, Juul J (1981) The complete amino acid sequence of a prototype immunoglobulin-lambda light-chain-type amyloid-fibril protein AR. Biochem J 195:561-572.
49. Skinner M, Benson MD, Cohen AS (1975) Amyloid fibril protein related to immunoglobulin lambdachains. J Immunol 114:1433-1435.
50. Conrad K, Roggenbuck D, Reinhold D, Dorner T (2010) Profiling of rheumatoid arthritis associated autoantibodies. Autoimmun Rev 9:431-435.
51. Tissot JD, Sanchez JC, Vuadens F, Scherl A, Schifferli JA, et al. (2002) IgM are associated to Sp alpha (CD5 antigen-like). Electrophoresis 23:1203-1206.
52. Skriner K, Adolph K, Jungblut PR, Burmester GR (2006) Association of citrullinated proteins with synovial exosomes. Arthritis Rheum 54:3809-3814.